» Articles » PMID: 14695211

Identification of Genes Expressed in Malignant Cells That Promote Invasion

Overview
Journal Cancer Res
Specialty Oncology
Date 2003 Dec 26
PMID 14695211
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

To systematically identify genes related to invasion a three-dimensional multicellular matrix invasion assay was used to classify human tumor cell lines as stromal invasion positive or stromal invasion negative. Cells from two of the primary cell types of the stromal compartment [endothelial cells (HMVEC) and myofibroblasts (HDF)] were assayed for invasion into tumor cell clusters (breast carcinoma, ovarian carcinoma, prostate carcinoma, lung carcinoma, and melanoma). Four tumor cell lines (MDA-MB231, SKOV-3, A375, and MEL624) scored invasion positive, and four tumor cell lines (LNCaP, DU145, PC3, and A549) scored invasion negative. Serial analysis of gene expression (SAGE) libraries generated from the tumor cell lines were analyzed by GeneSpring Hierarchical clustering, t test, and chi(2) test. Clusters emerged that reflected the behavior in the cell culture assay. Of the 47 most highly differentially expressed genes, 30 were selected for confirmation by real-time PCR, and 9 had good correlation with normalized serial analysis of gene expression tag counts. The strongest correlations were for bone marrow stromal antigen 2, stathmin-like 3, tumor necrosis factor receptor superfamily member 5, and hepatocyte growth factor tyrosine kinase substrate. In situ hybridization of metastatic and nonmetastatic ovarian cancer demonstrated selective expression of bone marrow stromal antigen 2 and tumor necrosis factor receptor superfamily member 5 in the metastatic disease. This combination approach appears to be a powerful tool for identifying genes that may be useful as diagnostic markers and/or as therapeutic targets for invasive solid tumors.

Citing Articles

Spatial transcriptome profiling identifies DTX3L and BST2 as key biomarkers in esophageal squamous cell carcinoma tumorigenesis.

Li R, Li N, Yang Q, Tong X, Wang W, Li C Genome Med. 2024; 16(1):148.

PMID: 39696540 PMC: 11657267. DOI: 10.1186/s13073-024-01422-4.


Increased BST-2 expression by HBV infection promotes HBV-associated HCC tumorigenesis.

Zhang J, Zheng B, Zhou X, Zheng T, Wang H, Wang Y J Gastrointest Oncol. 2021; 12(2):694-710.

PMID: 34012659 PMC: 8107608. DOI: 10.21037/jgo-20-356.


Tetherin/BST2, a physiologically and therapeutically relevant regulator of platelet receptor signalling.

Zhao X, Alibhai D, Sun T, Khalil J, Hutchinson J, Olzak K Blood Adv. 2021; 5(7):1884-1898.

PMID: 33792632 PMC: 8045503. DOI: 10.1182/bloodadvances.2020003182.


From 1957 to Nowadays: A Brief History of Epigenetics.

Peixoto P, Cartron P, Serandour A, Hervouet E Int J Mol Sci. 2020; 21(20).

PMID: 33066397 PMC: 7588895. DOI: 10.3390/ijms21207571.


Plasmacytoid dendritic cells in the eye.

Jamali A, Kenyon B, Ortiz G, Abou-Slaybi A, Sendra V, Harris D Prog Retin Eye Res. 2020; 80:100877.

PMID: 32717378 PMC: 7854822. DOI: 10.1016/j.preteyeres.2020.100877.